Advertisement
BN vs IVZ
Which Stock Would AI Choose? Brookfield Corporation (BN) vs. Invesco Ltd. (IVZ) Stock Comparison
Key Takeaways
- BN (Brookfield Corporation) operates as a global alternative asset manager with diversified holdings across real estate, infrastructure, and renewables, while IVZ (Invesco Ltd.) focuses on traditional and exchange-traded fund (ETF) asset management.
- In recent market activity, IVZ has demonstrated stronger price momentum with gains exceeding 17% over the past month, compared to more modest advances for BN.
- BN reported continued growth in fee-related earnings and record capital raises in recent quarters, supporting its position in alternative investments.
- IVZ benefited from robust client inflows and analyst price target increases following second-quarter 2026 results.
- Sector exposure differs markedly: BN emphasizes long-term alternative assets, whereas IVZ has greater sensitivity to equity market trends and ETF demand.
- Relative valuation and performance metrics highlight trade-offs between BN’s scale in alternatives and IVZ’s recent operational momentum.
Introduction
This comparison examines BN (Brookfield Corporation) and IVZ (Invesco Ltd.), two companies in the asset management sector with distinct business models. Brookfield emphasizes alternative investments, while Invesco maintains a broad platform including ETFs and active strategies. The analysis focuses on recent market behavior, operational developments, and positioning within the current environment. Professional investors evaluating sector allocation, as well as traders monitoring relative momentum, may find this overview useful for understanding performance differentials and risk profiles without reliance on forward-looking projections.
BN Overview and Recent Performance
BN (Brookfield Corporation) is a leading global alternative asset manager with operations spanning real estate, infrastructure, renewable power, and private equity. The firm manages substantial assets under management (AUM) and generates revenue through management fees and carried interest. In recent market activity, the stock has shown resilience amid broader equity fluctuations, posting modest gains in the low single digits over recent weeks while trading near $44. Developments such as record capital raises and growth in fee-related earnings have supported sentiment. Joint ventures and dividend announcements on preferred units have also featured in recent corporate updates, contributing to a stable operational backdrop for the diversified alternative investment platform.
IVZ Overview and Recent Performance
IVZ (Invesco Ltd.) is a global investment management company offering a wide range of active and passive strategies, with particular strength in ETFs. The firm serves institutional and retail clients across equities, fixed income, and alternative products. In recent market activity, the stock has advanced notably, with gains approaching or exceeding 17% over the past month and trading near $32. Second-quarter 2026 results highlighted higher operating revenues and client inflows, prompting several analyst firms to raise price targets. Broader equity market strength and sustained demand for lower-cost investment vehicles have influenced performance, positioning the company favorably within the traditional asset management space.
Trending AI Robots
Tickeron’s Trending AI Robots page showcases a curated selection of high-performing AI trading bots from its extensive library. Tickeron offers hundreds of AI Trading Bots that trade thousands of different tickers, yet only the most suitable for prevailing market conditions earn placement in this section. Available bots span a wide range of performance metrics, with many demonstrating annualized returns in double digits alongside varying drawdown profiles, win rates, and trade frequencies. Strategies include trend-following, mean-reversion, and momentum approaches across multiple timeframes, each tailored to distinct ticker sets and risk parameters. Readers interested in exploring these options can review the full selection on the Trending AI Robots page.
Head-to-Head Comparison
BN and IVZ operate in asset management but pursue different strategies. BN concentrates on illiquid alternative assets with longer investment horizons, exposing it to factors such as interest rate sensitivity and infrastructure cycles. IVZ maintains broader exposure to liquid markets through ETFs and active funds, resulting in greater correlation to equity indices and inflows driven by market sentiment. Recent momentum favors IVZ, while BN has emphasized capital deployment and fee growth. Risk considerations include BN’s leverage in alternatives versus IVZ’s dependence on AUM growth and fee compression pressures common in the ETF segment. Market positioning reflects these contrasts, with each offering distinct trade-offs in stability and responsiveness to short-term conditions.
Tickeron AI Verdict
Based on observable factors including recent trend consistency, earnings momentum, and relative positioning, Tickeron’s AI would currently assign a probabilistic edge to IVZ over BN. Stronger price appreciation in recent weeks, coupled with positive analyst revisions and inflow data, support this assessment. BN continues to demonstrate stability through its alternative asset focus, yet the comparative data tilt toward IVZ in the near term. This evaluation remains subject to evolving market conditions and should not be interpreted as a definitive recommendation.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BN is a Buy and IVZ is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BN’s FA Score shows that 0 FA rating(s) are green whileIVZ’s FA Score has 3 green FA rating(s).
- BN’s FA Score: 0 green, 5 red.
- IVZ’s FA Score: 3 green, 2 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BN’s TA Score shows that 6 TA indicator(s) are bullish while IVZ’s TA Score has 5 bullish TA indicator(s).
- BN’s TA Score: 6 bullish, 4 bearish.
- IVZ’s TA Score: 5 bullish, 4 bearish.
Price Growth
BN (@Investment Managers) experienced а -0.52% price change this week, while IVZ (@Investment Managers) price change was +3.30% for the same time period.
The average weekly price growth across all stocks in the @Investment Managers industry was -0.01%. For the same industry, the average monthly price growth was +2.98%, and the average quarterly price growth was +1.10%.
Reported Earning Dates
BN is expected to report earnings on Nov 12, 2026.
IVZ is expected to report earnings on Oct 27, 2026.
Industries' Descriptions
@Investment Managers (-0.01% weekly)Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.
| BN | IVZ | BN / IVZ | |
| Capitalization | 95.6B | 14.4B | 664% |
| EBITDA | 33.1B | 1.68B | 1,968% |
| Gain YTD | -4.126 | 26.801 | -15% |
| P/E Ratio | 79.17 | 19.48 | 406% |
| Revenue | 75.7B | 6.9B | 1,097% |
| Total Cash | N/A | N/A | - |
| Total Debt | 264B | 9.44B | 2,797% |
BN | IVZ | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 20 | 45 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 89 Overvalued | 12 Undervalued | |
PROFIT vs RISK RATING 1..100 | 35 | 42 | |
SMR RATING 1..100 | 89 | 93 | |
PRICE GROWTH RATING 1..100 | 60 | 10 | |
P/E GROWTH RATING 1..100 | 92 | 31 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
IVZ's Valuation (12) in the Investment Managers industry is significantly better than the same rating for BN (89). This means that IVZ’s stock grew significantly faster than BN’s over the last 12 months.
BN's Profit vs Risk Rating (35) in the Investment Managers industry is in the same range as IVZ (42). This means that BN’s stock grew similarly to IVZ’s over the last 12 months.
BN's SMR Rating (89) in the Investment Managers industry is in the same range as IVZ (93). This means that BN’s stock grew similarly to IVZ’s over the last 12 months.
IVZ's Price Growth Rating (10) in the Investment Managers industry is somewhat better than the same rating for BN (60). This means that IVZ’s stock grew somewhat faster than BN’s over the last 12 months.
IVZ's P/E Growth Rating (31) in the Investment Managers industry is somewhat better than the same rating for BN (92). This means that IVZ’s stock grew somewhat faster than BN’s over the last 12 months.
| BN | IVZ | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 80% | 4 days ago 63% |
| Stochastic ODDS (%) | 4 days ago 69% | 4 days ago 67% |
| Momentum ODDS (%) | 4 days ago 63% | 4 days ago 74% |
| MACD ODDS (%) | 4 days ago 63% | 4 days ago 76% |
| TrendWeek ODDS (%) | 4 days ago 63% | 4 days ago 71% |
| TrendMonth ODDS (%) | 4 days ago 58% | 4 days ago 68% |
| Advances ODDS (%) | 7 days ago 67% | 4 days ago 70% |
| Declines ODDS (%) | 12 days ago 66% | 11 days ago 68% |
| BollingerBands ODDS (%) | 4 days ago 67% | 4 days ago 60% |
| Aroon ODDS (%) | 4 days ago 76% | 4 days ago 66% |
Advertisement